Saiid Zarrabian - Net Worth and Insider Trading
Saiid Zarrabian Net Worth
The estimated net worth of Saiid Zarrabian is at least $683,931 dollars as of 2024-06-11. Saiid Zarrabian is the Director of La Jolla Pharmaceutical Co and owns about 109,919 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $683,696. Saiid Zarrabian is also the Head of Strategic Partnerships of Kintara Therapeutics Inc and owns about 1,122 shares of Kintara Therapeutics Inc (KTRA) stock worth over $235. Details can be seen in Saiid Zarrabian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Saiid Zarrabian has not made any transactions after 2021-12-07 and currently still holds the listed stock(s).
Transaction Summary of Saiid Zarrabian
Saiid Zarrabian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Saiid Zarrabian owns 2 companies in total, including Kintara Therapeutics Inc (KTRA) , and La Jolla Pharmaceutical Co (LJPC) .
Click here to see the complete history of Saiid Zarrabian’s form 4 insider trades.
Insider Ownership Summary of Saiid Zarrabian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KTRA | Kintara Therapeutics Inc | 2021-12-07 | director & Head of Strategic Partnerships |
| LJPC | La Jolla Pharmaceutical Co | 2015-05-14 | director |
Saiid Zarrabian Latest Holdings Summary
Saiid Zarrabian currently owns a total of 2 stocks. Among these stocks, Saiid Zarrabian owns 109,919 shares of La Jolla Pharmaceutical Co (LJPC) as of May 14, 2015, with a value of $683,696 and a weighting of 99.97%. Saiid Zarrabian also owns 1,122 shares of Kintara Therapeutics Inc (KTRA) as of December 7, 2021, with a value of $235 and a weighting of 0.03%.
Latest Holdings of Saiid Zarrabian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LJPC | La Jolla Pharmaceutical Co | 2015-05-14 | 109,919 | 6.22 | 683,696 |
| KTRA | Kintara Therapeutics Inc | 2021-12-07 | 1,122 | 0.21 | 235 |
Holding Weightings of Saiid Zarrabian
Saiid Zarrabian Form 4 Trading Tracker
According to the SEC Form 4 filings, Saiid Zarrabian has made a total of 0 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years. The most-recent trade in La Jolla Pharmaceutical Co is the acquisition of 307 shares on May 14, 2015, which cost Saiid Zarrabian around $5,987.
According to the SEC Form 4 filings, Saiid Zarrabian has made a total of 1 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 1,000 shares on December 7, 2021, which cost Saiid Zarrabian around $31,500.
Insider Trading History of Saiid Zarrabian
- 1
Saiid Zarrabian Trading Performance
GuruFocus tracks the stock performance after each of Saiid Zarrabian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saiid Zarrabian is 13.85%. GuruFocus also compares Saiid Zarrabian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Saiid Zarrabian within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Saiid Zarrabian's insider trading performs compared to the benchmark.
Performance of Saiid Zarrabian
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.73 | | | | | |
| Relative Return to S&P 500(%) | -2.19 | | | | | |
Saiid Zarrabian Ownership Network
Saiid Zarrabian Owned Company Details
What does Kintara Therapeutics Inc do?
Who are the key executives at Kintara Therapeutics Inc?
Saiid Zarrabian is the director & Head of Strategic Partnerships of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and Chief Scientific Officer Dennis M Brown .
Kintara Therapeutics Inc (KTRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kintara Therapeutics Inc Insider Transactions
Saiid Zarrabian Mailing Address
Above is the net worth, insider trading, and ownership report for Saiid Zarrabian. You might contact Saiid Zarrabian via mailing address: P.o. Box 675765, Rancho Santa Fe Ca 92067.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
